Trials / Sponsors / GeNeuro Innovation SAS
GeNeuro Innovation SAS
Industry · 7 registered clinical trials.
| Status | Trial | Phase | Started |
|---|---|---|---|
| Terminated | A Long-term Extension of Study GNC-401 Multiple Sclerosis | Phase 2 | 2021-08-27 |
| Completed | Clinical Trial Assessing Temelimab Following Rituximab Treatment in Patients With Relapsing Forms of Multiple Multiple Sclerosis | Phase 2 | 2020-06-17 |
| Completed | Safety Study of GNbAC1 Monoclonal Antibody in Healthy Male Volunteers Healthy Volunteers | Phase 1 | 2015-04-01 |
| Completed | Longitudinal Therapeutically Non-interventional Study of MSRV-Env Burden in Patients With Multiple Sclerosis D Multiple Sclerosis (MS), Relapsing-Remitting MS, Primary Progressive MS | — | 2012-11-01 |
| Completed | Longitudinal Therapeutically Non-interventional Study of MSRV-Env Burden in Normal Population Multiple Sclerosis | — | 2012-10-01 |
| Completed | Safety Study of GNbAC1 in Multiple Sclerosis Patients Multiple Sclerosis | Phase 2 | 2012-07-01 |
| Completed | First-in-Human Study With GNbAC1 in Healthy Volunteers Multiple Sclerosis | Phase 1 | 2011-07-01 |